We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Urgent public health message: UKHSA has been notified about an outbreak of food botulism in France involving a small number of British nationals.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Advice to give pregnant women on infections that can be transmitted via contact with animals that are or have recently given birth.
The management, surveillance and epidemiology of carbapenem resistance.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Form L5 for identification of Clostridium botulinum, Clostridium perfringens, Clostridium tetani, Escherichia coli, helicobacter, listeria and yersinia.
An overview of the process including submitting or fast tracking an application, naming your medicine and paying fees.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.
How to spot Batrachochytrium salamandrivorans, what to do if you suspect it and measures to prevent its spread.
This amended guidance was issued under s 182 of the Licensing Act 2003.
Fifteen additional synthetic opioids are now under the strictest controls to prevent drug related deaths and ensure anyone caught supplying them faces tough penalties.
Batches of some products made by Legency Remedies Pvt Ltd have been found to contain a bacteria called Ralstonia pickettii (R. pickettii). All potentially affected batches are being recalled following an MHRA investigation.
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
The What Works Network uses evidence to improve the design and delivery of public services.
Form L7 for the isolation, identification and toxin detection of clostridium botulinum and Staphylococcus aureus.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.